|
Volumn 61, Issue 5, 2001, Pages 1996-2001
|
Experimental chronotherapy of mouse mammary adenocarcinoma MA13/C with docetaxel and doxorubicin as single agents and in combination
a a a,c d b d a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DOCETAXEL;
DOXORUBICIN;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
BASE MISPAIRING;
BREAST ADENOCARCINOMA;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CELL PROLIFERATION;
CHRONOTHERAPY;
CIRCADIAN RHYTHM;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG TOLERABILITY;
GROWTH INHIBITION;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
TUMOR GROWTH;
ADENOCARCINOMA;
ANIMALS;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CIRCADIAN RHYTHM;
DOXORUBICIN;
DRUG ADMINISTRATION SCHEDULE;
HEART;
MALE;
MAMMARY NEOPLASMS, EXPERIMENTAL;
MICE;
MICE, INBRED C3H;
MICROSCOPY, ELECTRON;
MYOCARDIUM;
PACLITAXEL;
TAXOIDS;
|
EID: 0035266333
PISSN: 00085472
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (59)
|
References (21)
|